13therapeutics, Inc.

Novel Peptides for the Treatment of Inflammatory Diseases


13therapeutics, Inc is a research and drug development company identifying, characterizing, and optimizing novel anti-inflammatory peptide therapeutics for unmet medical needs with high commercial potential. 


The company has an innovative platform for discovering and enhancing peptides, derived from naturally occurring pathogens (e.g., bacteria, viruses, fungi), which modulate the human immune response.  This platform has produced a portfolio of peptides with demonstrated immune-regulatory activity and with varying mechanisms of action.